View Document Preview and Link Document Date: 2014-05-03 19:39:18 Open Document File Size: 199,05 KB Share Result on Facebook
City Seattle / Missoula / / Company AMP / CBC / COX / GW Pharmaceuticals / Elsevier Ltd. / Renault / / Country Switzerland / Netherlands / United States / Brazil / Jamaica / / Currency pence / / / Event FDA Phase / Product Recall / Product Issues / / Facility USA University of Montana Department / PubMed/National Library / UK University of Washington School / Arch Int Pharmacodyn Ther / / / IndustryTerm natural product / oil terpenoids / cancer treatment / pharmaceutical / oil / cannabis products / neurotransmitter systems / Migraine treatment / chemical phenotype / food deprivation / similar protocol / medicinal product / pharmaceutical preparations / usual protocol / travel expenses / / MedicalCondition headache / catatonia / seizures / chemotherapy-associated nausea / urinary incontinence / rheumatoid arthritis / ALS / intractable pain / Huntington’s disease / amyotrophic lateral sclerosis / tremor / gliomas / brachial plexus injury / secondarily generalized epilepsy / withdrawal syndrome / multiple sclerosis / tachycardia / Motor neurone disease / MS / cannabis abuse / REM-sleep deprivation / Dystonic disorders / Tourette syndrome / cancer / cerebral infarction / Parkinson disease / parkinsonian dyskinesia / CBD further slowed disease / THC Glioma / intractable cancer / severe and chronic pain / spasms / migraine / tumour / chronic administration / cocaine addiction / seizure / pain / complete seizure / frequently progressive degenerative diseases / drug abuse / Anti-Carcinogenesis Glioma / short-term memory loss / intractable chronic pain / Alzheimer disease / Migraine treatment Bipolar disease Dystonia Parkinsonian symptoms Withdrawal symptoms / spasm / neoplastic disorders / inflammation / murine collagen-induced arthritis / depression / including tachycardia / / MedicalTreatment chemotherapy / / Organization University of Washington School of Medicine / CBD administration / International Cannabinoid Research Society / University of Montana Department of Pharmaceutical Sciences / Administration of CBD / / Person Brit J Pharmacol / Alice Mead / Richard Musty / Calhoun SR / Emma Brierley / Ethan Russo / Geoffrey W. Guy / Carlini / / / Position editor / Grillo MP / Acknowledgements The author / consultant / author / Professor / Source The author / vari* Corresponding author / / Product Migraine treatment Bipolar disease Dystonia Parkinsonian symptoms / FS / LG PC12 Radio / Mechoulam R. Antipsychotic / Marinol / Cannador capsules / Opiate / THC / Scale-11 / MS / CBD / / ProvinceOrState Montana / Mississippi / / PublishedMedium Medical Hypotheses / / RadioStation Mo FM / Malfait AM / / Technology apoptosis / pharmacokinetics / usual protocol / chemotherapy / similar protocol / / URL http / SocialTag 
Medical Hypotheses[removed], 234–246 http://intl.elsevierhealth.com/journals/mehy A tale of two cannabinoids: The therapeutic rationale for combining